<DOC>
	<DOCNO>NCT00270426</DOCNO>
	<brief_summary>The purpose study determine whether benazepril , could safely slow progression renal dysfunction non-diabetic patient advance renal insufficiency .</brief_summary>
	<brief_title>Benazepril Advanced Chronic Renal Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<criteria>1. serum creatinine concentration 1.55.0 mg/dL ( 133442 µmol/L ) 2. creatinine clearance 20 to70 mL/min/1.73 m2 , variation less 30 percent three month screen evaluation 3. nondiabetic renal disease 4. persistent proteinuria ( define urinary protein excretion great 0.3 g/day three month without evidence urinarytract infection overt heart failure [ New York Heart Association class III–IV ] ) . immediate need dialysis ; treatment corticosteroid , nonsteroidal antiinflammatory drug immunosuppressive drug ; renovascular disease ; myocardial infarction cerebrovascular accident year precede trial ; connectivetissue disease ; obstructive uropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>Advanced Chronic Renal Insufficiency</keyword>
	<keyword>Benazepril</keyword>
</DOC>